Delivery Order SPE2DB20D2002-SPE2DB25FL49R
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,927.62 to AmerisourceBergen Drug Corp for TUBERSOL 5T Unit/0.1 ML Vial 5ML, a tuberculin skin test antigen product. The award was made on September 19, 2025, with an ultimate completion date of September 22, 2025. This non-competitive, firm fixed-price delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a $1,070.95 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for TUBERSOL 5T Unit/0.1 ML Vial 5ML, a tuberculosis skin test antigen used for diagnostic purposes. This non-set-aside competitive award is scheduled for completion by July 30, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $2,281.10 firm fixed price delivery order to AmerisourceBergen Drug Corp for TUBERSOL 5T Unit/0.1 ML Vial 5ML, a tuberculin skin test antigen used for tuberculosis screening. The award, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-competitive delivery order placed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $4,380.20 to AmerisourceBergen Drug Corp for Tubersol 5T Unit/0.1 ML Vial tuberculin skin test antigen. This competitively awarded, firm fixed-price delivery order was executed on August 29, 2025, with an ultimate completion date of September 2, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,179.04 on August 19, 2025, for the supply of Tubersol 5T Unit/0.1 mL vial 5mL tuberculin skin test antigen. This firm fixed price, non-set-aside contract is scheduled for completion by August 20, 2025, with performance at the contractor's location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,742.90 to supply Tubersol 5T Unit tuberculin skin test vials (0.1 mL, 5 mL format) with an ultimate completion date of June 13, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency for $1,155.00 to supply TUBERSOL 5T UNIT/0.1 ML VIAL tuberculosis skin test antigen. The contract, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- This delivery order, awarded on August 27, 2025, to AmerisourceBergen Drug Corp, provides $2,797.86 in firm fixed price pharmaceutical supplies to the Defense Logistics Agency. Specifically, the contract calls for delivery of Tubersol 5T tuberculin skin test units in 0.1 milliliter vials with 5 milliliter capacity to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with a completion date of August 28, 2025....
- The Defense Logistics Agency (DLA) awarded a $1,100 delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Tubersol 5T Unit/0.1 mL vials. This competitive, firm fixed-price contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The company will perform this delivery order from its corporate office location in Conshohocken,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, valued at $1,070.95, with a completion date of February 11, 2025. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL49RDelivery Order
The Defense Logistics Agency awarded a $2,141.90 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for Tubersol 5T Unit/0.1 ML Vial 5ML tuberculin skin test antigen. This firm fixed-price delivery order is scheduled for completion by June 17, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract utilized no set-aside designation, indicating competitive award through open bidding processes. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio demonstrates capability in delivering diverse pharmaceutical products, vaccines, and medical supplies to support military healthcare programs worldwide. This tuberculin antigen delivery represents a routine medical supply transaction within the company's ongoing engagement as a prime vendor for DLA's pharmaceutical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 6/16/25 |